Adverse Events as End Points: The Need to Account for Both Sides of the Same Coin

Adverse Events as End Points: The Need to Account for Both Sides of the Same Coin

Bibliographic Details
Main Author:	Felipe Aizpuru
Format:	Article
Language:	English
Published:	Wiley 2017-04-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	Editorials adverse drug event clinical trial regulation of research
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.117.006018

Similar Items

Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
by: Jennifer G. Le-Rademacher, et al.
Published: (2020-11-01)

The SMART Safety: An empirical dataset for evidence synthesis of adverse events
by: Shiqi Fan, et al.
Published: (2023-12-01)

Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
by: Ruoning Yang, et al.
Published: (2022-05-01)

Adverse events: an expensive and avoidable hospital problem
by: Diego San Jose-Saras, et al.
Published: (2022-12-01)

Appraisal of Intraoperative Adverse Events to Improve Postoperative Care
by: Larsa Gawria, et al.
Published: (2023-03-01)

Adverse Events of DOACs in Children
by: Alessandra Bosch, et al.
Published: (2022-07-01)

Three aspects of acupuncture-related adverse events: Issues around the reporting of acupuncture-related adverse events
by: Tae-Hun Kim, et al.
Published: (2023-09-01)

Rheumatological Adverse Events Following Immunotherapy for Cancer
by: Ioana Cretu, et al.
Published: (2022-01-01)

Inductive Characterization of ENDS-Associated Adverse Events Among California Young Adults
by: Joshua S. Yang, PhD, MPH, et al.
Published: (2022-12-01)

Adverse Events of Oncologic Immunotherapy and Their Management
by: Fedricker Diane Barber
Published: (2019-01-01)

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
by: Xue-Feng Jiao, et al.
Published: (2023-01-01)

Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trials
by: Brigitte Cheuvart, et al.
Published: (2023-12-01)

IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events
by: Stephanie L. Gu, et al.
Published: (2023-11-01)

Optimisation of Approaches to Adverse Event Analysis in Bioequivalence Clinical Trials
by: A. B. Verveda, et al.
Published: (2024-04-01)

Treatment-Related Adverse Events of Chimeric Antigen Receptor T-Cell (CAR T) in Clinical Trials: A Systematic Review and Meta-Analysis
by: Wen Lei, et al.
Published: (2021-08-01)

Signal mining and analysis for adverse events of avatrombopag based on FAERS
by: XIONG Rui, et al.
Published: (2024-02-01)

Adverse drug events caused by medication errors in medical inpatients
by: B Hardmeier, et al.
Published: (2004-11-01)

ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions
by: Hong Yu, et al.
Published: (2019-05-01)

Editorial: Immune-related adverse events for patients with lung cancer-volume II
by: Yusha Wang, et al.
Published: (2023-11-01)

Reducing preventable adverse events in obstetrics by improving interprofessional communication skills – Results of an intervention study
by: Beate Hüner, et al.
Published: (2023-01-01)

Cosmetics utilization and associated adverse events: A community based cross-sectional study
by: Sweta Kumari, et al.
Published: (2023-09-01)

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
by: Yunyan Pan, et al.
Published: (2024-04-01)

Treatment‐related adverse events of antibody‐drug conjugates in clinical trials: A systematic review and meta‐analysis
by: Jinming Li, et al.
Published: (2023-10-01)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
by: Yamin Shu, et al.
Published: (2023-05-01)

Perceptions of Clinical Adverse Event Reporting by Nurses and Midwives
by: Anna Majda, et al.
Published: (2024-02-01)

Some adverse events following immunization in veterinary medicine
by: Vesna Milićević, et al.
Published: (2018-09-01)

Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports
by: Michael S. Ewer, et al.
Published: (2022-07-01)

Effects of secukinumab and ixekizumab on major adverse cardiovascular events in patients with psoriasis: a meta-analysis of randomized controlled trials
by: Yonghong Zhang, et al.
Published: (2024-03-01)

Perception of the Disclosure of Adverse Events in a Latin American Culture: A National Survey
by: Thiago Gomes Romano, et al.
Published: (2022-08-01)

Auricular acupressure for adverse events following immunization after COVID-19 vaccine injection: A multicentre, blinded, randomized controlled trial
by: Qinwei Fu, et al.
Published: (2022-12-01)

A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases
by: Menglin He, et al.
Published: (2024-02-01)

Effect of intensive versus standard blood pressure control on major adverse cardiac events and serious adverse events: A bivariate analysis of randomized controlled trials
by: Gerald Chi, et al.
Published: (2019-02-01)

Prospective assessment of inter-rater reliability of a neonatal adverse event severity scale
by: Thomas Salaets, et al.
Published: (2023-09-01)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
by: Yankun Liang, et al.
Published: (2023-10-01)

Alpelisib-related adverse events: The FDA Adverse Event Reporting System Database (FAERS) pharmacovigilance study
by: Yun Li, et al.
Published: (2024-03-01)

OAE-based data mining and modeling analysis of adverse events associated with three licensed HPV vaccines
by: Wenrui Zi, et al.
Published: (2022-11-01)

Adverse Event Reporting Quality in Cancer Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy: A Systematic Review
by: Yuhong Wang, et al.
Published: (2022-07-01)

Enalapril‐induced angioedema: A forgotten adverse event
by: María Carolina Manzur‐Barbur, et al.
Published: (2022-06-01)

Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data
by: Peter Hanlon, et al.
Published: (2022-10-01)

Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
by: Wenfang Sun, et al.
Published: (2024-01-01)